Interim analysis of binary outcome data in clinical trials: a comparison of five estimators

References

• Breslow, N. E., and J. Crowley. (1974). A large sample study of the life table and product limit estimates under random censoring. Annals of Statistics 2:437—453. doi:10.1214/aos/1176342705.
   Web of Science ®Google Scholar
• Efron, B. (1967). The two-sample problem with censored data. Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability 4:831–852.
   Google Scholar
• FDA. (2010). Adaptive design clinical trials for drug and biologics draft guidance. http://www.fda.gov/downloads/Drugs/Guidances/ucm201790.pdf
   Google Scholar
• Galbraith, S., and I. C. Marschner. (2003). Interim analysis of continuous long-term endpoints in clinical trials with longitudinal outcomes. Statistics in Medicine (22):1787–1805. doi:10.1002/sim.1311.
   PubMedGoogle Scholar
• Gelber, R. D., A. Goldhirsch, and B. F. Cole. (1993). Parametric extrapolation of survival estimates with applications to quality of life evaluation of treatments. International breast cancer study group. Controlled Clinical Trials Society for Clinical Trials 14:485–499.
   PubMedGoogle Scholar
• Gill, R. D. (1980). Censoring and stochastic integrals. Mathematical Centre Tract 1980; No. 124. Amsterdam: Mathematisch Centrum.
   Google Scholar
• Gruder C. L., Mermelstein R. J., Kirkendol S., Hedeker D., Wong S. C., Schreckengost J. (1993). Effects of social support and relapse prevention training as adjuncts to a televised smoking cessation intervention. Journal of Consulting and Clinical Psychology 61:113–120. doi:10.1037/0022-006X.61.1.113.
   PubMed Web of Science ®Google Scholar
• Hampson, L. V., and C. Jennison. (2013). Group sequential tests for delayed responses. Journal Of The Royal Statistical Society Series B 75 (1):3–54. doi:10.1111/j.1467-9868.2012.01030.x.
   Google Scholar
• Kaplan, E. L., and P. Meier. (1958). Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 53 (282):457–481. doi:10.1080/01621459.1958.10501452.
   Web of Science ®Google Scholar
• Magirr, D., T. Jaki, and J. Whitehead. (2012). A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection. Biometrika 99:494–501. doi:10.1093/biomet/ass002.
   Web of Science ®Google Scholar
• Maller, R. A., and S. Zhou. (1992). Estimate the proportion of immunes in a censored sample. Biometrika 79 (4):731–739. doi:10.1093/biomet/79.4.731.
   Web of Science ®Google Scholar
• Marschner, I. C., and S. L. Becker. (2001). Interim monitoring of clinical trials based on long-term binary endpoints. Statistics in Medicine 20 (2):177–192.
   PubMed Web of Science ®Google Scholar
• Meier, P. (1975). Estimation of a distribution function from incomplete observations. In J. Gaui (Ed.), Perspectives in Probability and Statistics. England: Applied Probability Trust, Sheffield.
   Google Scholar
• Nunn, A. J., P. P. Phillips, and D. A. Mitchison. (2010). Timing of relapse in short-course chemotherapy trials for tuberculosis. The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union against Tuberculosis and Lung Disease 14 (2):241–242.
   PubMed Web of Science ®Google Scholar
• Parpia, S., J. A. Julian, and C. Gu. (2014). Thabane L and Levine MN. Interim analysis for binary outcome trials with a long fixed follow-up time and repeated outcome assessments at pre-specified times. SpringerPlus 3:323. doi:10.1186/2193-1801-3-323.
   PubMedGoogle Scholar
• Pedley, A. (2011). Applying survival analysis techniques to interim analysis and sample size reassessment of clinical trials with dichotomous endpoint. ProQuest, UMI Dissertations Publishing, Dissertation. Boston University.
   Google Scholar
• Royston, P., F. M. S. Barthel, M. K. B. Parmar, and B. C. Choodari-Oskooei. (2011). Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of efficacy. Trials 12:81.
   PubMed Web of Science ®Google Scholar
• Royston, P., M. K. B. Parmar, and W. Qian. (2003). Novel designs for multi-arm clinical trials with survival outcomes with an application in ovarian cancer. Statistics in Medicine 22:2239–2256. doi:10.1002/sim.1430.
   PubMed Web of Science ®Google Scholar
• Sooriyarachchi, M. R., J. Whitehead, A. Whitehead, and K. Bolland. (2006). The sequential analysis of repeated binary responses: A score test for the case of three time points. Statistics in Medicine 25 (12):2196–2214. doi:10.1002/sim.2339.
   PubMedGoogle Scholar
• Stallard, N. (2010). A confirmatory seamless phase II/III clinical trial design incorporating short-term endpoint information. Statistics in Medicine 29:959–971.
   PubMed Web of Science ®Google Scholar
• STAMPEDE Trial Development Group. (2004). STAMPEDE Protocol. London: MRC Clinical Trials Unit. http://www.stampedetrial.org/centres/information_for_centres/protocol_and_appendices.aspx
   Google Scholar
• Wason, J. M. S., and T. Jaki. (2012). Optimal design of multi-arm multi-stage trials. Statistics in Medicine 31:4269–4279. doi:10.1002/sim.5513.
   PubMed Web of Science ®Google Scholar
• Whitehead, A., M. R. Sooriyarachchi, J. Whitehead, and K. Bolland. (2008). Incorporating intermediate binary responses into interim analyses of clinical trials: A comparison of four methods. Statistics in Medicine 27 (10):1646–1666. doi:10.1002/sim.3348.
   PubMed Web of Science ®Google Scholar
• Zee, J., and S. Xie. (2018). The Kaplan-Meier method for estimating and computing proportions in a randomized controlled trial with dropouts. Biostatistics & Epidemiology 2 (1):23–33. doi:10.1080/24709360.2017.1407866.
   PubMedGoogle Scholar